These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Lymphomatoid papulosis evolving into malignant lymphoma. Clinico-pathological and immunohistochemical study of 3 cases]. Bustos de Abajo M; Serrano Ortega S; Medina Cano MT; Aguilar Peña D; Gutiérrez Salmerón MT; Gómez Morales M; García del Moral R Med Clin (Barc); 1993 Feb; 100(6):220-2. PubMed ID: 8429728 [TBL] [Abstract][Full Text] [Related]
4. The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Beljaards RC; Willemze R Br J Dermatol; 1992 Jun; 126(6):596-602. PubMed ID: 1610711 [TBL] [Abstract][Full Text] [Related]
5. Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature. McCarty MJ; Vukelja SJ; Sausville EA; Perry JJ; James WD; Jaffe ES; Weiss RB Cancer; 1994 Dec; 74(11):3051-8. PubMed ID: 7954268 [TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease. Kaudewitz P; Stein H; Plewig G; Schwarting R; Gerdes J; Burg G; Kind P; Eckert F; Braun-Falco O J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):999-1006. PubMed ID: 2370346 [TBL] [Abstract][Full Text] [Related]
8. Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Kunishige JH; McDonald H; Alvarez G; Johnson M; Prieto V; Duvic M Clin Exp Dermatol; 2009 Jul; 34(5):576-81. PubMed ID: 19196298 [TBL] [Abstract][Full Text] [Related]
15. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis. Wang HH; Myers T; Lach LJ; Hsieh CC; Kadin ME Cancer; 1999 Oct; 86(7):1240-5. PubMed ID: 10506709 [TBL] [Abstract][Full Text] [Related]
17. [Skin involvement in Hodgkin's disease]. Requena Caballero L; Sánchez López M; Requena Caballero C; Vázquez López F; Hernández Moro B Med Cutan Ibero Lat Am; 1988; 16(2):106-10. PubMed ID: 3050325 [TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
19. [Lymphomatoid papulosis in childhood: six case reports and a literature review]. Bories N; Thomas L; Phan A; Balme B; Salameire D; Thurot-Guillou C; Dalle S Ann Dermatol Venereol; 2008 Oct; 135(10):657-62. PubMed ID: 18929914 [TBL] [Abstract][Full Text] [Related]
20. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease. Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]